[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT89405B - Processo para a preparacao de derivados de isoquinolina e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de derivados de isoquinolina e de composicoes farmaceuticas que os contem

Info

Publication number
PT89405B
PT89405B PT89405A PT8940589A PT89405B PT 89405 B PT89405 B PT 89405B PT 89405 A PT89405 A PT 89405A PT 8940589 A PT8940589 A PT 8940589A PT 89405 B PT89405 B PT 89405B
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
isoquinoline derivatives
isoquinoline
Prior art date
Application number
PT89405A
Other languages
English (en)
Other versions
PT89405A (pt
Inventor
Klaus Hasspacher
Reto Naef
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT89405A publication Critical patent/PT89405A/pt
Publication of PT89405B publication Critical patent/PT89405B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT89405A 1988-01-08 1989-01-06 Processo para a preparacao de derivados de isoquinolina e de composicoes farmaceuticas que os contem PT89405B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888800397A GB8800397D0 (en) 1988-01-08 1988-01-08 Improvements in/relating to organic compounds

Publications (2)

Publication Number Publication Date
PT89405A PT89405A (pt) 1990-02-08
PT89405B true PT89405B (pt) 1993-09-30

Family

ID=10629678

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89405A PT89405B (pt) 1988-01-08 1989-01-06 Processo para a preparacao de derivados de isoquinolina e de composicoes farmaceuticas que os contem

Country Status (28)

Country Link
US (1) US4980359A (pt)
JP (1) JPH0649686B2 (pt)
KR (1) KR0142686B1 (pt)
AT (1) AT394365B (pt)
AU (1) AU622429B2 (pt)
BE (1) BE1002730A3 (pt)
CA (1) CA1332944C (pt)
CH (1) CH678727A5 (pt)
DE (1) DE3900233C2 (pt)
DK (1) DK5789A (pt)
ES (1) ES2010071A6 (pt)
FI (1) FI90865C (pt)
FR (1) FR2625743B1 (pt)
GB (2) GB8800397D0 (pt)
GR (1) GR1002750B (pt)
HU (1) HU205083B (pt)
IE (1) IE61914B1 (pt)
IL (1) IL88899A (pt)
IT (1) IT1229523B (pt)
LU (1) LU87423A1 (pt)
MY (1) MY103963A (pt)
NL (1) NL8900029A (pt)
NZ (1) NZ227561A (pt)
PH (1) PH25640A (pt)
PL (1) PL156099B1 (pt)
PT (1) PT89405B (pt)
SE (1) SE501548C2 (pt)
ZA (1) ZA89133B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723674A (en) * 1951-11-28 1955-11-15 Charles E Harris Telephone cableman's tent
US3007541A (en) * 1959-02-24 1961-11-07 Jr John B Mast Temporary covering and support structure therefor
GB8807922D0 (en) * 1988-04-05 1988-05-05 Fujisawa Pharmaceutical Co Isoquinoline compound & process for preparation thereof
US4956371A (en) * 1989-09-19 1990-09-11 Euroceltique, S.A. Substituted isoquinolines and methods of using same
GB8921304D0 (en) * 1989-09-20 1989-11-08 Wyeth John & Brother Ltd New method of treatment and heterocyclic compounds used therein
GB9027055D0 (en) * 1990-12-13 1991-02-06 Sandoz Ltd Organic compounds
HUT64676A (en) * 1990-12-17 1994-02-28 Shell Int Research Fungicidal compositions containing isoquinoline derivatives as actvie agent and process for production of the active agents
CA2093577C (en) * 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids
US5350423A (en) * 1992-09-23 1994-09-27 Burlington Industries Inc. Fabric finishing procedure
GB9322828D0 (en) * 1993-11-05 1993-12-22 Sandoz Ltd Organic compounds
US5783184A (en) * 1994-12-23 1998-07-21 Smithkline Beecham Corporation Method for treatment and diagnosis of IL-5 mediated disorders
US6129913A (en) * 1994-12-23 2000-10-10 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US7399837B2 (en) 1995-12-22 2008-07-15 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
US5693323A (en) * 1994-12-23 1997-12-02 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
GB9622386D0 (en) * 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
IT1296985B1 (it) 1997-12-19 1999-08-03 Zambon Spa Derivati benzazinici inibitori della fosfodiesterasi 4
AU2904300A (en) * 1999-01-15 2000-08-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
ATE447952T1 (de) 1999-08-21 2009-11-15 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
CA2517487A1 (en) 2003-04-01 2004-10-14 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
US20100086547A1 (en) * 2007-04-30 2010-04-08 Smithkline Beecham Corporation Methods for administering anti-il-5 antibodies
EP2274009B1 (en) 2008-03-28 2013-11-13 GlaxoSmithKline LLC Methods of treatment
KR20110071014A (ko) 2008-10-17 2011-06-27 위스콘신 얼럼나이 리서어치 화운데이션 생물학적으로 활성인 알파-베타 펩티드의 제조 방법
JP7295038B2 (ja) 2017-06-06 2023-06-20 グラクソスミスクライン エルエルシー 小児患者のための生物薬剤組成物及び方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB645139A (en) * 1946-10-22 1950-10-25 Servita Gyogyszeryar Es Vegyip Improved process for the production of isoquinoline derivatives
DE1184344B (de) * 1962-06-16 1964-12-31 Orgamol Sa Verfahren zur Herstellung von Isochinolinderivaten
US3878215A (en) * 1971-12-01 1975-04-15 Sandoz Ag 2-Alkyl-3-substituted-4-aryl isoquinolines
DE2401453A1 (de) * 1973-01-16 1974-07-18 John James Voorhees Pharmazeutische zusammensetzung zur behandlung von hautproliferationserkrankungen
US4018927A (en) * 1973-12-17 1977-04-19 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with papaverine alkaloids
DE2503156A1 (de) * 1974-02-05 1975-08-07 Sandoz Ag Verfahren zur herstellung neuer heterocyclischer verbindungen
DE2811361A1 (de) * 1978-03-16 1979-09-27 Hoechst Ag Neue isochinolinaldehyde und verfahren zu ihrer herstellung
DE3244594A1 (de) * 1982-12-02 1984-06-07 Hoechst Ag, 6230 Frankfurt 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung
HU196758B (en) * 1986-05-21 1989-01-30 Gyogyszerkutato Intezet Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them
PH25651A (en) * 1986-05-21 1991-08-21 Duphar Int Res New di, tetrahydroisoquinoline derivatives

Also Published As

Publication number Publication date
GB2213482B (en) 1991-09-11
HU205083B (en) 1992-03-30
FI890072A0 (fi) 1989-01-06
AT394365B (de) 1992-03-25
IT1229523B (it) 1991-09-04
ES2010071A6 (es) 1989-10-16
SE8900039L (sv) 1989-07-09
GB8800397D0 (en) 1988-02-10
ZA89133B (en) 1990-09-26
IL88899A0 (en) 1989-08-15
DE3900233C2 (de) 2000-04-27
HUT52061A (en) 1990-06-28
ATA3589A (de) 1991-09-15
JPH01213267A (ja) 1989-08-28
JPH0649686B2 (ja) 1994-06-29
MY103963A (en) 1993-10-30
AU2779589A (en) 1989-07-20
AU622429B2 (en) 1992-04-09
DE3900233A1 (de) 1989-07-20
US4980359A (en) 1990-12-25
IE890037L (en) 1989-07-08
FI90865B (fi) 1993-12-31
GR890100008A (el) 1994-03-31
CH678727A5 (pt) 1991-10-31
GR1002750B (el) 1997-08-26
DK5789D0 (da) 1989-01-06
FI890072A (fi) 1989-07-09
FI90865C (fi) 1994-04-11
NL8900029A (nl) 1989-08-01
BE1002730A3 (fr) 1991-05-21
CA1332944C (en) 1994-11-08
PT89405A (pt) 1990-02-08
GB8900102D0 (en) 1989-03-01
LU87423A1 (fr) 1989-08-30
PL156099B1 (pl) 1992-02-28
GB2213482A (en) 1989-08-16
FR2625743B1 (fr) 1990-11-09
NZ227561A (en) 1991-11-26
SE501548C2 (sv) 1995-03-13
DK5789A (da) 1989-07-09
IT8947504A0 (it) 1989-01-04
KR0142686B1 (ko) 1998-07-15
PH25640A (en) 1991-08-21
SE8900039D0 (sv) 1989-01-05
FR2625743A1 (fr) 1989-07-13
KR890011851A (ko) 1989-08-22
PL277092A1 (en) 1989-09-04
IL88899A (en) 1994-07-31
IE61914B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
PT89661A (pt) Processo para a preparacao de compostos pirrolicos substituidos e de composicoes farmaceuticas que os contem
PT92497A (pt) Processo para a preparacao de derivados de ureia de dipeptideos inibidores de enzimas, e de composicoes farmaceuticas que os contem
PT89405B (pt) Processo para a preparacao de derivados de isoquinolina e de composicoes farmaceuticas que os contem
PT82985B (pt) Processo para a preparacao de derivados de distamicina e de composicoes farmaceuticas que os contem
PT97114A (pt) Processo para a preparacao de derivados de hidantoina e de composicoes farmaceuticas que os contem
PT81041B (pt) Processo para a preparacao de derivados de etilenodiamina-monoamida e de composicoes farmaceuticas que os contem
PT82307B (pt) Processo para a preparacao de derivados da 4'-demetil-4-epipodofilotoxina e de composicoes farmaceuticas que os contem
PT99795A (pt) Processo para a preparacao e novos derivados de piperidinil-benzimidazol e de composicoes farmaceuticas que os contem
PT84187B (pt) Processo para a preparacao de novos derivados da isoquinolina e de composicoes farmaceuticas que os contem
PT83558B (pt) Processo para a preparacao de derivados da carboxamida e de composicoes farmaceuticas que os contem
PT84462B (pt) Rocesso para a preparacao de novos tiazois e oxazois substituidos e de composicoes farmaceuticas que os contem
PT90172A (pt) Processo para a preparacao de n-benzopiranillactames insaturados e de composicoes farmaceuticas que os contem
PT83604B (pt) Processo para a preparacao de derivados da flavona e de composicoes farmaceuticas que os contem
PT91870A (pt) Processo para apreparacao de novas quinoliloxazol-2-onas e de composicoes farmaceuticas que as contem
PT83559B (pt) Processo para a preparacao de novos derivados de indol e indazol-ceto-sulfona e de composicoes farmaceuticas que os contem
PT90864A (pt) Processo para a preparacao de derivados de cromano e de composicoes farmaceuticas que os contem
PT89145A (pt) Processo para a preparacao de derivados da manumicina e de composicoes farmaceuticas que os contem
PT88351A (pt) Processo para a preparacao de derivados de isoxazol-beta-carbolina e de composicoes farmaceuticas que os contem
PT90721A (pt) Processo para a preparacao de compostos de imidazoquinoxalina e de composicoes farmaceuticas que os contem
PT91803A (pt) Processo para a preparacao de novos derivados da 2'-halogenometilideno-, 2'-etenilideno- e 2'-etinil-adenosina e de composicoes farmaceuticas que os contem
PT91979A (pt) Processo para a preparacao de derivados de cromano e de composicoes farmaceuticas que os contem
PT90904A (pt) Processo para a preparacao de derivados de 3-oxo-propanonitrilo triciclicos e de composicoes farmaceuticas que os contem
PT82440B (pt) Processo para a preparacao de eteres ciclopentilicos e de composicoes farmaceuticas que os contem
PT89214A (pt) Processo para a preparacao de novos derivados de aminoacidos ciclicos e de composicoes farmaceuticas que os contem
PT89614A (pt) Processo para a preparacao de derivados dos acidos quinolonoe naftiridono-carboxilicos e de composicoes antibacterianas que os contem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19930330

PC3A Transfer or assignment

Free format text: 971017 NOVARTIS AG CH

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20010930